Old Web
English
Sign In
Acemap
>
authorDetail
>
Ryo Akazawa
Ryo Akazawa
Kyoto University
Medicine
Oncology
Internal medicine
Osteosarcoma
Temozolomide
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inotuzumabozogamicin is an effective treatment for CD22‐positive acute undifferentiated leukemia: A case report
2021
Pediatric Blood & Cancer
Ryo Akazawa
Itaru Kato
Hirohito Kubota
Kiyotaka Isobe
Hiroaki Masuno
Masamitsu Mikami
Mitsutaka Shiota
Kagehiro Kouzuki
Naoko Kawabata
Kuniaki Tanaka
Satoshi Saida
Katsutsugu Umeda
Hidefumi Hiramatsu
Souichi Adachi
Junko Takita
Show All
Source
Cite
Save
Citations (0)
Inotuzumab ozogamicin following allogeneic hematopoietic stem cell transplantation successfully rescued relapse of CD19-negative acute lymphoblastic leukemia after CAR-T cell therapy.
2021
Pediatric Blood & Cancer
Tatsuya Kamitori
Katsutsugu Umeda
Ryo Akazawa
Atsushi Iwai
Satoshi Obu
Kiyotaka Isobe
Satoshi Saida
Itaru Kato
Hidefumi Hiramatsu
Takashi Taga
Souichi Adachi
Junko Takita
Show All
Source
Cite
Save
Citations (0)
Temozolomide and etoposide combination for the treatment of relapsed osteosarcoma.
2020
Japanese Journal of Clinical Oncology
Ryo Akazawa
Katsutsugu Umeda
Satoshi Saida
Itaru Kato
Hidefumi Hiramatsu
Akio Sakamoto
Yoshiki Arakawa
Shinji Sumiyoshi
Takeshi Okamoto
Hiroshi Moritake
Souichi Adachi
Junko Takita
Show All
Source
Cite
Save
Citations (0)
Refractory autoimmune hemolytic anemia following bone marrow transplantation in an infant patient with congenital amegakaryocytic thrombocytopenia
2019
Keiji Tasaka
Katsutsugu Umeda
Ryo Akazawa
Tatsuya Kamitori
Kiyotaka Isobe
Itaru Kato
Hidefumi Hiramatsu
Yukako Maeda
Tomoo Daifu
Souichi Adachi
Junko Takita
Show All
Source
Cite
Save
Citations (0)
頻回再発骨肉腫に対するテモゾロミド/エトポシドの治療効果 Temozolomide and etoposide for multiple relapses of osteosarcoma
2018
Ryo Akazawa
Show All
Source
Cite
Save
Citations (0)
1